
Adalimumab pen
Form: Pre-filled Syringe or Pen
Strength: 40 mg/0.8 mL, 40 mg/0.4 mL
Reference Brands: Humira (US & EU)
Category: Arthritis
Adalimumab pen is approved in the EU and US for rheumatoid arthritis and other autoimmune diseases. In the EU, brands like Humira are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data, biosimilarity assessments, and pharmacovigilance. Both regions require detailed dossiers for approval and continued safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for adalimumab pens, ensuring adherence to European and American standards for safe, effective biologic therapy, and helping you navigate complex regulatory processes seamlessly.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Pegloticase injecatble
Strength: 8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details Get EnquiryColchicine tablest
Strength: 0.6 mg
Form: Tablet
Reference Brands: Colcrys(US)
View Details Get EnquiryFebuxostat tablets
Strength: 40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details Get EnquiryAllopurinol tablets
Strength: 100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View Details Get Enquiry